Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Bambusa Therapeutics, Inc. (BBTX) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
BBTXBambusa Therapeutics, Inc.$17.16$848.44M―14.48%―Unlock the BBTX analyst price target with TipRanks PremiumBBTXUnlock the BBTX top-analyst price target with TipRanks Premium
RGNXRegenXBio$8.47$508.48M-2.64-26.67%Strong BuyUnlock the RGNX analyst price target with TipRanks PremiumBBTX vs RGNXUnlock the RGNX top-analyst price target with TipRanks Premium
EDITEditas Medicine$2.38$386.62M-3.85-10.53%Strong BuyUnlock the EDIT analyst price target with TipRanks PremiumBBTX vs EDITUnlock the EDIT top-analyst price target with TipRanks Premium
MGTXMeiragtx Holdings$9.68$923.93M12.748.76%Strong BuyUnlock the MGTX analyst price target with TipRanks PremiumBBTX vs MGTXUnlock the MGTX top-analyst price target with TipRanks Premium
FDMT4D Molecular Therapeutics$12.99$688.34M-4.7820.28%Strong BuyUnlock the FDMT analyst price target with TipRanks PremiumBBTX vs FDMTUnlock the FDMT top-analyst price target with TipRanks Premium
PRMEPrime Medicine, Inc.$4.30$707.37M-3.919.69%Strong BuyUnlock the PRME analyst price target with TipRanks PremiumBBTX vs PRMEUnlock the PRME top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
BBTXBambusa Therapeutics, Inc.17.162.1714.48%
RGNXRegenXBio8.47-3.17-27.23%
EDITEditas Medicine2.38-0.16-6.30%
MGTXMeiragtx Holdings9.681.4217.19%
FDMT4D Molecular Therapeutics12.992.7126.36%
PRMEPrime Medicine, Inc.4.300.9729.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts